therascreen® FGFR RGQ RT-PCR Kit
- Primary DI
- 04053228043560
- Brand
- therascreen® FGFR RGQ RT-PCR Kit
- Company
- QIAGEN GmbH
- Model
- 2
- Catalog number
- 874721
- Device description
- The therascreen FGFR RGQ RT-PCR Kit is a real-time, reverse transcription PCR test for the qualitative detection of two point mutations in exon 7 [p.R248C (c.742C>T), p.S249C (c.746C>G)], two point mutations in exon 10 [p.G370C (c.1108G>T) and p.Y373C (c.1118A>G)] and two fusions (FGFR3-TACC3v1 and FGFR3-TACC3v3) in the fibroblast growth factor receptor 3 (FGFR3) gene in RNA samples derived from formalin-fixed paraffin-embedded (FFPE) urothelial tumor tissue. The test is indicated for use as an aid in identifying patients with cases of urothelial cancer (UC) which harbor these alterations and are therefore eligible for treatment with BALVERSA™ (erdafitinib).Specimens are processed using the RNeasy DSP FFPE Kit for manual sample preparation followed by reverse transcription and then automated amplification and detection on the Rotor-Gene Q MDx (US) instrument.
- Published
- 2022-05-23
- Public version status
- New
- Distribution status
- In Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- Rx
- true
Contact Domains#
Product Codes#
| Code | Name |
|---|---|
| OWD | Somatic Gene Mutation Detection System |
Product Code Classifications#
| Code | Device | Specialty | Class |
|---|---|---|---|
| OWD | Somatic Gene Mutation Detection System | Unknown | 3 |
Premarket Submissions#
| Submission | Supplement |
|---|---|
| P180043 | 001 |
Premarket Details#
Identifiers And Packaging#
| Identifier | Type | Agency | Package quantity | Status |
|---|---|---|---|---|
| 04053228043560 | Primary | GS1 | 0 |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized | EAN-13 |
|---|---|---|
| 04053228043560 | 04053228043560 | 4053228043560 |
GMDN Terms#
| Term | Definition |
|---|---|
| Fibroblast growth factor receptor (FGFR) gene mutation IVD, kit, nucleic acid technique (NAT) | A collection of reagents and other associated materials intended to be used to help select cancer treatment options and/or monitor the response to cancer therapy by determining the mutation status of the fibroblast growth factor receptor (FGFR) gene, using a using a nucleic acid technique (NAT). It is intended to be used to select urothelial cancer patients for pan-FGFR tyrosine kinase inhibitor (e.g., erdafitinib) therapy. |
Storage And Handling#
| Type | Low | High | Condition |
|---|---|---|---|
| Special Storage Condition, Specify | 0 | 0 | Store in a constant temperature freezer. Protect from light. |
| Storage Environment Temperature | -90 Degrees Celsius | -15 Degrees Celsius |
Sterilization Methods#
| Method |
|---|
Contacts#
| Phone | |
|---|---|
| 800-362-7737 | techservice-na@qiagen.com |
Regulatory Flags#
- DUNS number
- 317103745
- Device count
- 1
- Kit
- true
- Lot or batch
- true
- Expiration date on label
- true
Other Devices From This Company#
| Primary DI | Brand | Model | Catalog | Published |
|---|---|---|---|---|
| 04053228040576 | EZ2 Connect MDx | 9003230 | 9003230 | 2026-03-03 |
| 04053228039402 | QIAstat-Dx® Respiratory Panel Plus | V1 | 691224 | 2025-09-25 |
| 04053228043850 | QIAstat-Dx® Meningitis/Encephalitis (ME) Panel | V2 | 691621 | 2025-10-31 |
| 04053228048381 | QIAstat-Dx® GI Panel 2 Mini B | V1 | 691423 | 2025-03-28 |
| 04053228049166 | QIAstat-Dx® GI Panel 2 Mini B&V | V1 | 691424 | 2025-02-18 |
| 04053228048862 | QIAstat-Dx® Respiratory Panel Mini | V1 | 691218 | 2024-12-05 |
| 04053228043249 | QIAstat-Dx® Gastrointestinal Panel 2 | V1 | 691421 | 2024-06-17 |
| 14053228039409 | QIAstat-Dx® Respiratory Panel Plus | V1 | 691224 | 2025-09-25 |
| 04053228047438 | QIAstat-Dx® Respiratory Panel Plus | V1 | 691224 | 2024-06-17 |
| 04053228041849 | QIAstat-Dx® Rise | 1 | 9003163 | 2025-09-05 |
| 04053228040972 | CMV Primer ASR | V1 | 1124260 | 2021-06-02 |
| 04053228040996 | CMV Probe ASR | V1 | 1124264 | 2021-06-02 |
| 04053228048770 | QIAcuityDx® Four | 1 | 911060 | 2024-09-30 |
| 04053228047582 | QIAstat-Dx Analyzer 2.0 | 1 | 9002828 | 2024-09-18 |
| 04053228033936 | QIAstat-Dx® Analyzer 1.0 | v1 | 9002824 | 2019-05-24 |
| 04053228010838 | Rotor-Gene® Q MDx | 1 | 9002035 | 2016-09-24 |
| 04053228035725 | therascreen® BRAF RGQ PCR Kit | 1 | 874821 | 2020-06-11 |
| 04053228049418 | QIAcuityDx® Universal MasterMix Kit | 1 | 260101 | 2024-09-30 |
| 04053228049432 | QIAcuityDx® Universal MasterMix Kit | 1 | 260102 | 2024-09-30 |
| 04053228033905 | QIAstat-Dx® Respiratory Panel | V1 | 691221 | 2019-05-24 |
Other Devices Sharing Product Codes#
| Primary DI | Brand | Company | Product code | Published |
|---|---|---|---|---|
| 04053228034834 | therascreen® PDGFRA RGQ PCR Kit | QIAGEN GmbH | OWD | 2024-12-10 |
| 00810022732571 | LeukoStrat | INVIVOSCRIBE, INC. | OWD | 2023-05-30 |
| 00054749005505 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-10-05 |
| 00875197005592 | cobas® EZH2 Mutation Test | Roche Molecular Systems, Inc. | OWD | 2020-08-01 |
| 00054749005123 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005147 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005154 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005161 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005178 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005185 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005192 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005208 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005215 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005222 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 00054749005529 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-07-01 |
| 04053228035725 | therascreen® BRAF RGQ PCR Kit | QIAGEN GmbH | OWD | 2020-06-11 |
| 00850052003739 | LeukoStrat | INVIVOSCRIBE, INC. | OWD | 2020-06-08 |
| 00850052003685 | LeukoStrat | INVIVOSCRIBE, INC. | OWD | 2020-05-29 |
| 00054749005512 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2020-05-01 |
| 00054749005093 | i-STAT | ABBOTT POINT OF CARE INC. | OWD | 2019-12-20 |
| 04053228034223 | therascreen® PIK3CA RGQ PCR Kit | QIAGEN GmbH | OWD | 2019-06-05 |
| 04053228034094 | therascreen® FGFR RGQ RT-PCR Kit | QIAGEN GmbH | OWD | 2019-04-29 |
| 00884999047792 | RealTime | ABBOTT MOLECULAR INC. | OWD | 2018-08-06 |
| 00884999047341 | RealTime | ABBOTT MOLECULAR INC. | OWD | 2018-07-30 |
| 00884999047358 | RealTime | ABBOTT MOLECULAR INC. | OWD | 2018-07-30 |
| 00884999047037 | RealTime | ABBOTT MOLECULAR INC. | OWD | 2017-08-11 |
| 00884999047044 | RealTime | ABBOTT MOLECULAR INC. | OWD | 2017-08-11 |
| 00884999047051 | RealTime | ABBOTT MOLECULAR INC. | OWD | 2017-08-11 |
| 03573026559823 | THxID™ BRAF | BIOMERIEUX SA | OWD | 2017-05-12 |
| 04053228002048 | therascreen® KRAS RGQ PCR Kit | QIAGEN GmbH | OWD | 2017-01-04 |